
Edinburgh family in desperate race to get treatment in US for teen with cancer
Our community members are treated to special offers, promotions and adverts from us and our partners. You can check out at any time. More info
An Edinburgh mum is hoping to fundraise £80,000 to get her daughter life-changing cancer treatment in the US - that could save her vision.
Beau Johnston was first diagnosed with brain cancer when she was just two, and despite 17 years of chemotherapy, along with surgery, the tumour has left her visually impaired.
Now 19, the Glasgow University Law and French student has had eight courses of chemo to continually shrink her Hypothalamic Optic Pathway Glioma. Unfortunately, recent scans following her last chemotherapy regime showed a new tumour sitting on her remaining visual nerve fibres.
Her mum, Emma, told Edinburgh Live: "Over the years, she's usually managed to get 18 months to two years before she starts another chemo regime because the tumours grow and start to threaten things. The original tumour took away her sight in the right eye and left her with only half of the visual field in the left eye and took away one of the branches of circulation in the brain but with the vision she's got, she's done remarkably well.
"She got straight As at school, she was head girl, she got into study Law and French at Glasgow University and she managed, despite chemotherapy last year, to get through."
Over the years, Beau has also raised awareness of childhood cancer, appearing in this year's BBC Children in Need campaign, is an active member and trustee in the Scottish Youth Parliament, and is the lead singer in her beloved band, Low Tide.
(Image: Supplied)
Her mum said: "She's done eight courses of chemotherapy in total, when her tumours have grown again and got to the stage where they're going to be pressing on vital structures and causing problems so she's had a rough time over the years and we were hoping it was going to get better.
"She was going to transition into adult services for her ongoing care and the scan that was done, which is five months after her last chemo regime stopped, has shown a brand new tumour. Unfortunately that's sitting right on her remaining visual nerve fibres and is causing a little bit of reaction that they can see on scans. It's already irritating those fibres that allow her to see."
Beau and her family thought a new drug in the United States, Tovorafenib, would be the key to saving her vision but after they were told about the new tumour, they also received the devastating news that the drug had been bought by a new pharmaceutical company and was no longer available for compassionate access in the UK.
Emma continued: "She needs to find treatment to try and prevent her from losing her sight and turning blind and to control the growth of her brain tumours to prevent further damage to her health. If she doesn't, the tumours are likely to continue to grow, taking away her remaining vision, firstly, rendering her blind, and continuing to cause further damage to healthy brain tissue and function.
"We're completely stuck. We were hoping to be able to try [Tovorafenib] but the problem is we just cant access it in the UK at the moment. We've contacted IPSEN (the pharmaceutical company) and they're stuck, there's nothing that they can do because they aren't even in production of it themselves yet."
(Image: Supplied)
Emma has been left with no other choice but to go public and fundraise the money she will need to either take her daughter to the states to access the drug, or to import it to the UK- both of which will cost a significant amount of money.
While there's no guarantee that the new drug would work for Beau, the trials have given the family hope. Without it Beau will have no choice but to try radiation or proton therapy, both of which are known to have long term side affects.
She continued: "It's a new drug, we don't know the long lasting side affects like we do with the other drugs or the proton or radio therapy, so we're not comparing like with like in terms of knowing what the long term affects are but on paper the initial results look very promising and I think increasingly Cancers will be treated by targeting the mutations that are allowing them to grow.
"The problem is that because it's brand new, it's incredibly expensive because the company has to cover their research and development costs.
"I think we all understand that but its heart-breaking when you know that essentially there's a drug that might be able to help treat her and save her vision with hardly any side affects, as opposed to a traditional, older fashioned treatment that we know will have side effects."
"If it does work that would be amazing, if it does work and shrink it down that would be fantastic. We're in a difficult position and I think the thing that's been really hard is that we thought this was available but we've been caught with the drug changing hands."
The fundraiser is the family's Hail Mary. While they've tried to think of other ways to get the money or access the vital medication, they need to get the funds together in just a few weeks and they're quickly running out of time.
Emma added: "I was just thinking 'how on earth are we going to achieve this' because it's the time frame, the short time frame to be able to access the sums of money that we're talking about. You can sell your house but you just can't do it in this time frame, and I wouldn't have that equity in it. It's just difficult.
"I think Beau's got so much more to give and it would be tragic for her to lose her vision and her independence because we haven't been able to access the correct drug for her tumour.
"It's not fun and it's not fun to have to go public either but we don't really have a choice. I need to know I tried everything I can do as a mum to try and get the drug for her."
The drug alone costs £35,000 but they also need funds to get them there - or get the medication here. Emma is asking for help in getting as close as possible to the £80,000 mark, as soon as possible.
You can find more information on Beau, and donate to the fundraiser, here.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Scottish Sun
5 hours ago
- Scottish Sun
Taking common contraceptive pill long-term could increase your risk of life-threatening brain tumour, scientists warn
Find out all the pros and cons of the contraceptive pill below BITTER PILL Taking common contraceptive pill long-term could increase your risk of life-threatening brain tumour, scientists warn TAKING a progesterone-only contraceptive pill for more than five years is linked to an increased risk of a life-threatening brain tumour, say scientists. Desogestrel is a synthetic progestogen hormone used in oral contraceptives, specifically the progestogen-only pill (POP) or mini-pill. 1 Long-term use of desogestrel has been linked to intracranial meningiomas Credit: Science Photo Library - Getty While it offers several benefits beyond preventing pregnancy, such as regulating the menstrual cycle, reducing heavy or painful periods, new research suggests taking it continuously for more than five years is linked to a small increased risk of developing an intracranial meningioma. An intracranial meningioma is a tumour that develops from the meninges, the layers of tissue that cover the brain and spinal cord. These tumours are typically benign (non-cancerous) and slow-growing. But they can be life-threatening depending on size, location, and growth rate. The tumours are more common in older women, but previous studies lack information on the specific type of progestogen used - and risk has not been measured for continuous, current, and long term use. In the study from France published by The BMJ, researchers set out to assess the real-life risk of the brain tumour and short-term (less than a year) and prolonged (one to seven or more years) use of oral contraceptives containing desogestrel 75µg, levonorgestrel 30µg, or levonorgestrel 50-150 µg combined with oestrogen. Their findings were based on data from the French national health data system (SNDS) for 8,391 women who had undergone surgery for intracranial meningioma in 2020-2023. Each case was matched to 10 control women without meningioma of the same age and area of residence. The results showed a small increased risk associated with use of desogestrel for more than five continuous years. An increased risk wasn't found for shorter durations or when desogestrel had been discontinued for more than one year. Women taking fat jabs need 'effective contraception' - as health chiefs warn of serious harm to unborn babies The risk was greater in women older than 45 and after prolonged use of one of the known high risk progestogens before desogestrel. Although the researchers added the risk disappeared one year after stopping taking the pill. It was estimated that 67,000 women would need to use desogestrel for one woman to need surgery for intracranial meningioma, and 17,000 women if current use was for more than five years. No increased risk was found for levonorgestrel, alone or combined with oestrogen, regardless of duration of use. The researchers suggested desogestrel be discontinued if an intracranial meningioma is identified and patients monitored rather than undergoing immediate surgery.


Daily Mirror
11 hours ago
- Daily Mirror
Mums fighting scandal 'bigger than thalidomide' up for Pride of Britain award
The Mirror spoke to the two mums at the heart of a campaign for compensation for victims of an epilepsy drug that caused up to 20,000 children to be born with birth defects Two mothers who have been fighting a scandal even bigger than thalidomide say they are 'shocked' to be nominated for a Pride of Britain award. Mums Janet Williams and Emma Murphy have been campaigning for years for compensation for victims of an epilepsy drug that caused up to 20,000 children to be born with birth defects. Among tens of thousands of remarkable individuals and groups who have received nominations, they were delighted to hear they had been nominated by a member of the public. 'It makes all the work we have been doing for the past 12 years worthwhile,' says Janet, 60, from Pilling, Lancashire. 'It's the first time anything like this has happened to be quite truthful with you. Emma and I are both sat here in shock at the news.' The news that they had been put forward for this year's Special Recognition category at Pride of Britain with P&O Cruises was delivered as the two campaigners, Janet and Emma, 44, from Manchester, were on their way to London for a meeting with MPs to get a response to their claim for compensation. They both have epilepsy and were prescribed sodium valproate throughout their pregnancies, having been told by doctors that it was safe to keep taking. The pair set up In-Fact (the Independent Fetal Anti Convulsant Trust) in 2012, to find and support families like theirs. Both have children who have been affected by exposure to the drug. Sodium valproate has been licensed since 1973 to treat epilepsy, but as early as the 1980s reports of babies being born with deformities to mothers taking it began to surface. Up to 20,000 people have been affected by what is now known as foetal valproate spectrum disorder (F.V.S.D) which can result in physical malformations, autism and developmental delays. Their campaign led to a report published in February 2024 by England's patient safety commissioner, Dr Henrietta Hughes, which recommended a compensation scheme for families of children harmed by valproate taken in pregnancy. Hughes has suggested initial payments of £100,000 and described the damage caused by the drug as 'a bigger scandal than thalidomide'. However, their campaign for redress has stalled. Janet says: 'We felt we were at the cusp of a victory but the government kept putting it off.' Now Janet and Emma are expecting action from the government. 'We're hoping about 20 MPs come to the round table meeting so we can talk to them about the Hughes report and get a response. 'We've waited around 16 months now so it's really time to push on forward. 'And we hope that along with the compensation, one of the results of the meeting is that an amendment will be made to the mental health bill to include the needs of disabled persons, whose disabilities were caused as a result of their mother taking the anticonvulsant drug during pregnancy.' Previous awards in this category have gone to the NHS infected blood scandal, the Post Office and Hillsborough Family Support Group. Last year campaigners Michelle Tolley, Andy Evans and Jason Evans were rewarded for their tireless work on behalf of relatives and victims of the biggest scandal in NHS history, which left 30,000 people infected with HIV and Hepatitis C after being treated with contaminated blood and blood products. In 2023, Alan Bates won the Pride of Britain Special Recognition Award for exposing the truth about the Post Office scandal, and getting justice for sub postmasters whose lives it destroyed, while Margaret Aspinall, who lost her son James at Hillsborough, accepted an award on behalf of all the families in 2013. Do you know a campaign that has gone above and beyond to help others? If you do, please consider nominating them for a Pride of Britain award. How to nominate Campaigns that change the world are at the heart of Pride of Britain, and over the past 26 years, some truly dedicated work by community-minded people have inspired the nation. If you know a campaign that deserves an award, like the previous winners on this page, you can nominate them for: SPECIAL RECOGNITION For achievements not covered in other categories, such as inspiring carers, campaigners and members of armed forces. P&O CRUISES INSPIRATION AWARD Celebrating a remarkable individual or group who inspires everyone around them, or the wider world,with their positive spirit and awe-inspiring journey to achieve, or overcome adversity. They may deserve recognition for an extraordinary reaction to a defining or pivotal moment, or perhaps their actions have had an extraordinary impact. ITV FUNDRAISER OF THE YEAR For tireless and inspirational charity fundraising, open to people aged 18 and over. To reward a young person aged 17 and under for inspirational charity work. THIS MORNING LOCAL HERO For an individual or group that goes to remarkable lengths to help people around them in their local area. LIFETIME ACHIEVEMENT To recognise far-reaching achievement, possibly on a national or international scale. EMERGENCY SERVICES AWARD For police, fire, ambulance, paramedics or air, sea or mountain rescue who have gone beyond the call of duty. OUTSTANDING BRAVERY For adults who risk their own safety to help others who are in danger. For battling against the odds to help others, or a courageous act to save someone in danger. For achievements not covered in other categories, such as inspiring carers, campaigners and members of armed forces. Do you know a remarkable person who makes the world a better place? It only takes a minute to nominate them at Don't worry if you're not sure which category to choose – our team reads every nomination and will make sure all nominees are considered for the most appropriate award.


Edinburgh Live
12 hours ago
- Edinburgh Live
West Lothian man's back pain dismissed as 'wear and tear' was incurable cancer
Our community members are treated to special offers, promotions and adverts from us and our partners. You can check out at any time. More info A West Lothian man unknowingly climbed Ben Nevis with a broken back and incurable blood cancer. Harry Cartmill, a local councillor for Bathgate, scaled Scotland's highest mountain while putting up with severe back pain - which had earlier been dismissed as wear and tear which he was given painkillers for. However, it then emerged the pain was actually due to Harry having two broken vertebrae which was then diagnosed as Myeloma. Harry completed the hike in 2019 for a fourth time, reports the West Lothian Courier. Being 53 at the time, he admitted his back pain was 'bothering him' as he struggled on the way down. He is now raising awareness of the condition in the lead-up to Myeloma Awareness Week to ensure patients receive an early diagnosis. Despite being the third most common type of blood cancer, myeloma is frequently missed. Symptoms including back pain, easily broken bones, fatigue and recurring infection, are vague and often linked to general ageing or minor conditions. Harry said: "I've had two stem cell transplants and there have been hard times but I'm still here six years later. Not only still here but still living life to the full. (Image: Myeloma UK) "If something doesn't feel right, mention it. Get it checked. Less than two months before diagnosis I climbed Ben Nevis. I was an amateur athlete, so having a bit of pain didn't stop me. But my back was bothering me when I did it, I was really struggling on the way down. "I used to walk up Ben Nevis like it didn't exist and I thought, 'It must be old age kicking in'. Of course it was nothing to do with that." Harry has since lost two inches in height after doctors drilled into his hip before his diagnosis. As an avid golfer and climber, he had initially put his pain down to ageing and "wear and tear." Prescribed painkillers, he realises the shooting pain was unlike any he'd felt before and was in a different part of his back, which should have raised the alarm with his GP. Harry continued: "I'd had great health my whole life. When you push yourself, climbing mountains, or cycling 100 miles and running half marathons, you're used to a bit of pain. "I went to the doctor and he told me to take it easy, cut back on the golf, take painkillers. He said I was getting a bit older. But the pain progressively got worse. I think there needs to be an awareness there for some GPs. Not everybody with a pain in their spine has been overdoing it in the garden or playing too much golf. "The last week-and-a-half before I was diagnosed, I was really struggling. I knew something was wrong. I knew it wasn't just Father Time catching up with me. But I never thought it could be myeloma." Another GP at his practice, realised something was wrong and sent Harry for an X-ray, which showed he had two broken vertebrae. He was quickly diagnosed with myeloma. Join Edinburgh Live's Whatsapp Community here and get the latest news sent straight to your messages Harry continued: "When they saw the broken bones, they asked me if I'd had some kind of trauma, if I had fallen off my bike. So that rang alarm bells. A day or two later they drilled into my hip and that's when the diagnosis of myeloma came. I used to be almost 6ft and now I'm just over 5ft 9in. My spine is not as straight as it once was." Harry started chemotherapy and later received a stem cell transplant. "The treatment was incredibly hard," Harry admits. "I was a skeleton who could barely walk up the stairs." Unfortunately, Harry's cancer returned after just 18 months and he underwent chemotherapy again, followed by a second stem cell transplant. Two years on he is still in remission and determined to live a full life. He attended his daughter's wedding in May and last year celebrated a year in remission and his dog's 12th birthday by climbing Tinto Hill. "When you get a second chance, or a third chance as I was given, you have to make the best of every day with your family, your friends, your pets," said Harry. "I'm 60 at the start of next year and that would be a great milestone to reach, and I'm hoping that I can, because when I was diagnosed I didn't think I would get to that. I'm lucky to be alive." Dr Sophie Castell, Chief Executive at blood cancer charity Myeloma UK, said: We know that myeloma can be difficult to diagnose, so bring the Myeloma UK Symptom Translator with you to the GP, ask for answers and get to the bottom of what's causing your pain, infections or fatigue." For more information about myeloma or to download the symptom translator visit: Myeloma UK also run an Infoline, call 0800 980 3332.